Marubeni acquires stake in Lunatus

To bridge the Japan-Middle East pharmaceutical markets

START READING

Friday 19 August 2022

Marubeni Corporation, a Japanese trading and investment business conglomerate, has acquired a minority stake in Dubai-based Lunatus, a Middle East healthcare turnkey solutions provider.

Lunatus specializes in handling regulatory, marketing, sales, distribution, and supply chain management for international pharmaceutical and medical device companies. Established in 2013, its network covers the Gulf and Levant regions.

Through this acquisition, Marubeni seeks to bridge the Japan and Middle East markets. It will bring Japanese pharmaceuticals and medical devices to the Middle East and Africa to meet the increasing demand in the region.

By leveraging their joint expertise, Marubeni and Lunatus will explore expanding the business across other emerging markets including Southeast Asia and Africa. Marubeni has its healthcare and medical industry business network in China and the ASEAN countries.

Incorporated in 1949, Marubeni Corporation has 132 branches and offices, including 29 overseas subsidiaries.

The Marubeni Group uses its business networks within Japan and overseas to conduct importing and exporting as well as domestic business across wide-ranging fields. Additionally, it makes internal and external investments and is involved in resource development.